Vitamin C pp 73-85 | Cite as

Vitamin C and Infectious Diseases

  • H. Hemilä
Conference paper


Early in this century several authors suggested that vitamin C intake may have beneficial effects on the incidence and severity of various infections. Two exhaustive bibliographical searches of the old literature on vitamin C and infections have been published. One of them was overenthusiastic [1] in its interpretation of the findings, whereas the other was overly pessimistic [2]; neither offered any statistical analysis of the available data. However, a quantitative analysis of controlled studies has been published recently [3]. The mechanisms whereby vitamin C affects the immune system are poorly understood, although there are reports indicating that it affects the functions of phagocytes, the proliferation of T lymphocytes, the production of interferon, and the replication of viruses [3–5].


Chronic Granulomatous Disease Rheumatic Fever Common Cold Posttransfusion Hepatitis Recurrent Herpes Labialis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stone I (1972) The healing factor: vitamin C against disease. Grosset and Dunlap, New YorkGoogle Scholar
  2. 2.
    Briggs M (1984) Vitamin C and infectious disease. In: Briggs MH (ed) Recent vitamin research. CRC Press, Boca Raton, pp 39–81Google Scholar
  3. 3.
    Hemilä H (1997) Vitamin C and infectious diseases. In: Packer L, Fuchs J (eds) Vitamin C in health and disease. Dekker, New York, pp 471–503Google Scholar
  4. 4.
    Cunningham-Rundles WF, Berner Y, Cunningham-Rundles S (1993) Interaction of vitamin C in lymphocyte activation: current status and possible mechanisms of action. In: Cunningham-Rundles S (ed) Nutrient modulation of the immune response. Dekker, New York, pp 91–103Google Scholar
  5. 5.
    Jariwalla RJ, Harakeh S (1996) Antiviral and immunomodulatory activities of ascorbic acid. Subcell Biochem 25:215–231Google Scholar
  6. 6.
    Nishikimi M, Yagi K (1996) Biochemistry and molecular biology of ascorbic acid biosynthesis. Subcell Biochem 25:17–39PubMedGoogle Scholar
  7. 7.
    Perla D, Marmorston J (1937) Role of vitamin C in resistance. Arch Pathol 23:543–575; 683–712Google Scholar
  8. 8.
    Leichtentritt B (1924) Der Ablauf der Tuberkulose des Meerschweinchens bei Darreichung von akzessorischen Närhstoffen. Dtsch Med Wochenschr 50:672–673Google Scholar
  9. 9.
    Nassau E, Scherzer M (1924) Skorbut und Infekt beim Meerschweinchen. Klin Wochenschr 3:314–316Google Scholar
  10. 10.
    Heymann B (1926) Versuche an Meerschweinchen über die Beziehungen zwischen Skorbut und chronischer Tuberkulose. Klin Wochenschr 5:59–62Google Scholar
  11. 11.
    Bieling R (1927) Unterernährung und Infektion. Dtsch Med Wochenschr 53:182–183Google Scholar
  12. 12.
    Borghi B (1933) Trypanosomiasi ed avitaminosi. Atti Accad Lincei 17:665–671Google Scholar
  13. 13.
    Basu NK (1934) Tuberculosis and deficiency of vitamins. Int J Vitam Nutr Res 3:91–93Google Scholar
  14. 14.
    Euler H, Malmberg M (1934) Ein Anti-Pneumonie-Faktor in C-Vitamin-haltigen Früchten. Naturwissenschaften 22:205Google Scholar
  15. 15.
    Rinehart JF (1935) Studies relating vitamin C deficiency to rheumatic fever and rheumatoid arthritis: rheumatic fever. Ann Intern Med 9:586–599Google Scholar
  16. 16.
    Schultz MP (1936) Cardiovascular and arthritic lesions in guinea-pigs with chronic scurvy and hemolytic streptococcic infections. Arch Pathol 21:472–495Google Scholar
  17. 17.
    Scoz G, Cattaneo C (1936) Hypovitaminosis C and experimental tuberculosis. Boll Soc Ital Biol Sper 11:909–911Google Scholar
  18. 18.
    Taylor S (1937) Scruvy and carditis. Lancet 1:973–979Google Scholar
  19. 19.
    Montalti M, Passerini P (1938) Influenza dell’acido ascorbico sulla produzione sperimentale di agglutinine antitifiche. Boll 1st Sieroterap Milan 17:495–503Google Scholar
  20. 20.
    Ardy C (1939) Vitamina C e potere opsonico del sangue. Pathologica 31:384–388Google Scholar
  21. 21.
    Pecorella F (1940) Vitamina C ed anticorpi agglutinati. Boll 1st Sieroterap Milan 19:9–14Google Scholar
  22. 22.
    Jusatz HJ (1939) Ueber den Einfluss von Vitamin C auf Immunitätsvorgänge. Int J Vitam Nutr Res 9:75–95Google Scholar
  23. 23.
    Vasile B (1940) Influenza della vitamina C in forti dosi nella infezione sperimentale da bacterium coli. Boll Ist Sieroterap Milan 19:44–47Google Scholar
  24. 24.
    Kleimenhagen P (1941) Ueber den Einfluss von Vitamin C auf tuberkulös infizierte Meerschweinchen. Int J Vitam Nutr Res 11:209–227Google Scholar
  25. 25.
    Jones CM, Bartlett MK, Ryan AE, Drummey GD (1943) The effect of sulfanilamide powder on the healing of sterile and infected wounds. N Engl J Med 229:642–646Google Scholar
  26. 26.
    Meyer E, Meyer MB (1944) The pathology of Staphylococcus abscesses in vitamin C-deficent guinea pigs. Bull Johns Hopkins Hosp 74:98–117Google Scholar
  27. 27.
    Nigro T (1945) Complesso vitaminico C e difesa umorale. Pathologica 37:29–34Google Scholar
  28. 28.
    Barilli L, Paradiso M, Moggi P (1952) L’azione della vitamina C sul Mycobacterium tuberculosis. Riv Clin Pediatr 50:334–338PubMedGoogle Scholar
  29. 29.
    Bank S (1975) Prevention of rabies by vitamin C. Nature 258:153–154Google Scholar
  30. 30.
    Bank S (1977) Prophylactic effect of vitamin C on the incidence of rabies in guinea pigs inoculated with fixed rabies virus. Int J Vitam Nutr Res [Suppl 16]:235–244Google Scholar
  31. 31.
    Goldschmidt MC, Masin WJ, Brown LR, Wyde PR (1988) The effect of ascorbic acid deficiency on leukocyte phagocytosis and killing of Actinomyces viscosus. Int J Vitam Nutr Res 58:326–334PubMedGoogle Scholar
  32. 32.
    Sabin AB (1939) Vitamin C in relation to experimental poliomyelitis with incidental observations on certain manifestations in Macacus rhesus monkeys on a scorbutic diet. J Exp Med 69:507–515PubMedGoogle Scholar
  33. 33.
    Murphy BL, Krushak DH, Maynard JE, Bradley DW (1974) Ascorbic acid and its effects on parainfluenza type III virus infection in cotton-topped marmosets. Lab Anim Sci 24:229–232PubMedGoogle Scholar
  34. 34.
    Locke A, Locke RB, Bragdon RJ, Mellon RR (1937) Fitness, sulfanilamide and pneu-mococcus infection in the rabbit. Science 86:228–229PubMedGoogle Scholar
  35. 35.
    Messina L, Verga G (1937) L’azione dell’acido ascorbico sulla fagocitosi in vitro. Giorn Batteriol Immunol 19:850–855Google Scholar
  36. 36.
    Cattaneo C, Morellini M (1939) Reazioni immunitarie e sostanze riducenti. Boll Ist Sieroterap Milan 18:52–56Google Scholar
  37. 37.
    Büsing KH (1939) Vitamin C als Heilmittel gegen Infektionen. München Med Wschr 86:575–579; 822–823Google Scholar
  38. 38.
    Cosentino G (1939) Acido ascorbico ed ormone cortico-surrenale nel trattamento locale di peritoniti acute sperimentali. Giorn Batteriol Immunol 23:531–550Google Scholar
  39. 39.
    Osborn TWB, Gear JHS (1940) Possible relation between ability to synthesize vitamin C and reaction to tubercle bacillus. Nature 145:974Google Scholar
  40. 40.
    Pauling L (1970) Vitamin C and the common cold. Freeman, San Francisco [German translation: (1972) Vitamin C und der Schnupfen. Verlag Chemie, Weinheim]Google Scholar
  41. 41.
    Pauling L (1971) The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad Sci USA 68:2678–2681PubMedGoogle Scholar
  42. 42.
    Kleijnen J, Riet G, Knipschild PG (1989) Vitamine C en verkoudheid. Ned Tijdschr Geneeskd 133:1532–1535PubMedGoogle Scholar
  43. 43.
    Hemilä H (1997) Vitamin C intake and susceptibility to the common cold. Br J Nutr 77:59–72; 78:861–866Google Scholar
  44. 44.
    Hemilä H (1996) Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress. Int J Sports Med 17:379–383PubMedGoogle Scholar
  45. 45.
    Bessel-Lorck C (1959) Erkältungsprophylaxe bei Jugendlichen im Skilager. Med Welt(44):2126–2127Google Scholar
  46. 46.
    Baird IM, Hughes RE, Wilson HK, Davies JEW, Howard AN (1979) The effects of ascorbic acid and flavonoids on the occurrence of symptoms normally associated with the common cold. Am J Clin Nutr 32:1686–1690PubMedGoogle Scholar
  47. 47.
    Hemilä H (1997) Vitamin C supplementation and the common cold. Was Linus Pauling right or wrong? Int J Vitam Nutr Res 67:329–335PubMedGoogle Scholar
  48. 48.
    Hemilä H (1992) Vitamin C and the common cold. Br J Nutr 67:3–16PubMedGoogle Scholar
  49. 49.
    Hemilä H (1994) Does vitamin C alleviate the symptoms of the common cold? A review of current evidence. Scand J Infect Dis 26:1–6PubMedGoogle Scholar
  50. 50.
    Douglas RM, Chalker EB, Treacy B (1998) Vitamin C for the common cold. In: Acute respiratory infections module of The Cochrane Database of Systematic Reviews [updated 1 Dec 1997]. Available in The Cochrane Library [database on disk and CDROM]: The Cochrane Collaboration; Issue 1. Oxford: Update Software; (Updated quarterly)Google Scholar
  51. 51.
    Hemilä H (1998) Vitamin C supplementation and common cold symptoms. Factors affecting the magnitude of the benefit. Med Hypotheses (in press)Google Scholar
  52. 52.
    Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM (1975) Ascorbic acid for the common cold. JAMA 231:1038–1042Google Scholar
  53. 53.
    Hemilä H (1996) Vitamin C, the placebo effect, and the common cold: a case study of how preconceptions influence the analysis of results. J Clin Epidemiol 49:1079–1084, 1087PubMedGoogle Scholar
  54. 54.
    Asfora J (1977) Vitamin C in high doses in the treatment of the common cold. Int J Vitam Nutr Res [Suppl 16]:219–234Google Scholar
  55. 55.
    Szent-Györgyi A (1978) How new understandings about the biological function of ascorbic acid may profoundly affect our lives. Exec Health 14(8): 1–4Google Scholar
  56. 56.
    Gander J, Niederberger W (1936) Vitamin C in der Pneumonie-Behandlung. München Med Wochenschr 83:2074–2077Google Scholar
  57. 57.
    Hochwald A (1936) Beobachtungen über Ascorbinsäurewirkung bei der croupösen Pneumonie. Wien Arch Inn Med 29:353–374Google Scholar
  58. 58.
    Bohnholtzer E (1937) Beitrag zur Frage der Pneumoniebehandlung mit vitamin C. Dtsch Med Wochenschr 63:1001–1003Google Scholar
  59. 59.
    Hochwald A (1937) Vitamin C in der Behandlung der kruppösen Pneumonie. Dtsch Med Wochenschr 63:182–184Google Scholar
  60. 60.
    Posarelli S (1938) Sul trattamento delle polmoniti con la vitamina C. Policlinico (sezprat) 45:2138–2142Google Scholar
  61. 61.
    Ravetta M, Rettanni G (1938) Ricerche sulle proprietà terapeutiche della vitamina C. Gazz Ospedali Clin 69:771–786Google Scholar
  62. 62.
    Szirmai F (1940) Über den Wert des C-Vitamins in der Behandlung einzelner akuter Infektionskrankheiten. Dtsch Arch Klin Med 85:434–443Google Scholar
  63. 63.
    Kienner FR (1948) Virus pneumonia and its treatment with vitamin C. South Med Surg 110:36–38,46Google Scholar
  64. 64.
    Luberoff BJ (1978) Symptomectomy with vitamin C. A chat with Robert Cathcart. Chemtech 8:76–86Google Scholar
  65. 65.
    Cathcart RF (1981) Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Med Hypotheses 7:1359–1376PubMedGoogle Scholar
  66. 66.
    Hunt C, Chakravorty NK, Annan G, Habibzadeh N, Schorah CJ (1994) The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res 64:212–219PubMedGoogle Scholar
  67. 67.
    Glazebrook AJ, Thomson S (1942) The administration of vitamin C in a large institution and its effect on general health and resistance to infection. J Hygiene 42:1–19Google Scholar
  68. 68.
    Kimbarowski JA, Mokrow NJ (1967) Farbige Ausfällungsreaktion des Harns nach Kimbarowski, als Index der Wirkung von Ascorbinsäure bei Behandlung der Virusgrippe. Dtsch Gesundheitsw 22:2413–2418PubMedGoogle Scholar
  69. 69.
    Pitt HA, Costrini AM (1979) Vitamin C prophylaxis in marine recruits. JAMA 241:908–911PubMedGoogle Scholar
  70. 70.
    Hemilä H (1997) Vitamin C intake and susceptibility to pneumonia. Pediatr Infect Dis J 16:836–837PubMedGoogle Scholar
  71. 71.
    Pauling L (1986) How to live longer and feel better. Freeman, New York [German translation: (1990) Linus Pauling’s Vitamin-Programm: Plädoyer für ein gesundes Leben. Bertelsmann, Munich]Google Scholar
  72. 72.
    Ritzel G (1961) Kritische Beurteilung des Vitamins C als Prophylacticum und Therapeuticum der Erkältungskrankheiten. Helv Med Acta 28:63–68PubMedGoogle Scholar
  73. 73.
    Ritzel G (1976) Ascorbic acid and the common cold. JAMA 235:1108PubMedGoogle Scholar
  74. 74.
    Terezhalmy GT, Bottomley WK, Pelleu GB (1978) The use of water-soluble bioflavonoid-ascorbic acid complex in the treatment of recurrent herpes labialis. Oral Surg 45:56–62PubMedGoogle Scholar
  75. 75.
    Hasselbach F (1936) Vitamin C und Lungentuberkulose. Z Tuberk 75:336–347Google Scholar
  76. 76.
    Albrecht E (1938) Vitamin C als Adjuvans in der Therapie der Lungentuberkulose. Med Klin 34:972–973Google Scholar
  77. 77.
    Bauer G, Vorwerk W (1938) Beitrag zum Vitamin C-Defizit bei Lungentuberkulösen. Beitr Klin Tuberk 91:262–272Google Scholar
  78. 78.
    Hasselbach F (1938) Vitamine und Tuberkulose. Int J Vitam Nutr Res 7:152–173Google Scholar
  79. 79.
    Melzer E (1938) Über die Größe des Vitamin C-Defizits und seine therapeutische Bedeutung bei Lungentuberkulose. Dtsch Tuberk Bl 12:290–295Google Scholar
  80. 80.
    Pilz I (1938) Beeinflussung tuberkulös-exsudativer Schübe durch Vitamin C. Wien Med Wochenschr 88:1091–1093Google Scholar
  81. 81.
    Scartozzi C (1938) Rapporti tra vitamine e alcuni poteri immunitari. Vitamina C. Giorn Batteriol Immunol 21:902–932Google Scholar
  82. 82.
    Trautwein H (1938) Die Ascorbinsäure in der Behandlung der Lungentuberkulose. Beitr Klin Tuberk 91:411–421Google Scholar
  83. 83.
    Borsalino G (1937) La fragilità capillare nella tubercolosi polmonare e le sue modi-ficazioni per azione della vitamin C. Giorn Clin Med 18:273–294Google Scholar
  84. 84.
    Warns EHJ (1938) De invloed van vitamine C op het beloop van been- en gewricht-stubercolose. Ned Tijdschr Geneesk 82:4426–4435Google Scholar
  85. 85.
    Baur H, Staub H (1954) Hepatitistherapie mit Ascorbinsäureinfusionen. Schweiz Med Wochenschr 84:595–597PubMedGoogle Scholar
  86. 86.
    Kirchmair H (1957) Die Hepatitis epidemica im Kindesalter und ihre Behandlung mit hohen Dosen Ascorbinsäure. Dtsch Gesundheitsw 12:1525–1536PubMedGoogle Scholar
  87. 87.
    Baetgen D (1961) Ergebnisse der Behandlung der Hepatitis epidemica im Kindesalter mit hohen Dosen Ascorbinsäure in den Jahren 1957/58. Med Monatsschr 15:30–36PubMedGoogle Scholar
  88. 88.
    Calleja HB, Brooks RH (1960) Acute hepatitis treated with high doses of vitamin C. Report of a case. Ohio Med J 56:821–823PubMedGoogle Scholar
  89. 89.
    Dalton WL (1962) Massive doses of vitamin C in the treatment of viral diseases. J Indiana Med Assoc 55:1151–1154Google Scholar
  90. 90.
    Bank S, Kosak M (1979) Prevention of posttransfusion hepatitis by vitamin C. Int J Vitam Nutr Res [Suppl 19]:41–44Google Scholar
  91. 91.
    Pauling L (1981) Vitamin C prophylaxis for posttransfusion hepatitis. Am J Clin Nutr 34:1978–1979PubMedGoogle Scholar
  92. 92.
    Patrone F, Dallegri F (1979) Vitamina C e sistema fagocitario: recenti acquisizioni e prospettive. Acta Vitaminol Enzymol 1:5–10PubMedGoogle Scholar
  93. 93.
    Rebora A, Crovato F, Dallegri F, Patrone F (1980) Repeated staphylococcal pyoderma in two siblings with defective neutrophil bacterial killing. Dermatologica 160:106–112PubMedGoogle Scholar
  94. 94.
    Rebora A, Dallegri F, Patrone F (1980) Neutrophil dysfunction and repeated infections. Br J Dermatol 102:49–56PubMedGoogle Scholar
  95. 95.
    Patrone F, Dallegri F, Bonvini E, Minervini F, Sacchetti C (1982) Effects of ascorbic acid on neutrophil function. Studies on normal and chronic granulomatous disease neutrophils. Acta Vitaminol Enzymol 4:163–168PubMedGoogle Scholar
  96. 96.
    Patrone F, Dallegri F, Bonvini E, Minervini F, Sacchetti C (1982) Disorders of neutrophil function in children with recurrent pyogenic infections. Med Microbiol Immunol 171:113–122PubMedGoogle Scholar
  97. 97.
    Colombo ML, Girardo E, Incarbone E, Conti R, Ricci BM, Maina D (1989) Vitamina C in bambini affetti da trisomia 21. Minerva Pediatr 41:189–192PubMedGoogle Scholar
  98. 98.
    Levy R, Shriker O, Porath A, Riesenberg K, Schlaeffer F (1996) Vitamin C for the treatment of recurrent furunculosis in patients with impaired neutrophil functions. J Infect Dis 173:1502–1505PubMedGoogle Scholar
  99. 99.
    Pauling L (1977) Albert Szent-Györgyi and vitamin C. In: Kaminer B (ed) Search and discovery: a tribute to Albert Szent-Györgyi. Academic, New York, pp 43–54Google Scholar
  100. 100.
    Szent-Györgyi A (1934) Die medizinische Bedeutung des Vitamins C. Dtsch Med Wochenschr 60:556–557Google Scholar
  101. 101.
    Szent-Györgyi A (1934) Die medizinische und biologische Bedeutung des Vitamins C. Verh Dtsch Ges Inn Med (46th Congr):426–435Google Scholar
  102. 102.
    Szent-Györgyi A (1937) Neuere Ausblicke der Vitamintherapie. Dtsch Med Wochenschr 63:1789–1791Google Scholar
  103. 103.
    Szent-Györgyi A (1977) On a substance that can make us sick (if we do not eat it!). Exec Health 13(9):l-6Google Scholar
  104. 104.
    Chalmers TC (1975) Effects of ascorbic acid on the common cold. Am J Med 58:532–536PubMedGoogle Scholar
  105. 105.
    Dykes MHM, Meier P (1975) Ascorbic acid and the common cold. JAMA 231:1073–1079PubMedGoogle Scholar
  106. 106.
    Truswell AS (1986) Ascorbic acid. N Engl J Med 315:709 (minireview)Google Scholar
  107. 107.
    Hemilä H, Herman ZS (1995) Vitamin C and the common cold: a retrospective analysis of Chalmers’ review. J Am Coll Nutr 14:116–123PubMedGoogle Scholar
  108. 108.
    Hemilä H (1996) Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition 12:804–809PubMedGoogle Scholar
  109. 109.
    Chalmers TC (1996) Dissent to the preceding article by H. Hemilä. J Clin Epidemiol 49:1085Google Scholar
  110. 110.
    Liberati A (1996) Thomas C Chalmers. Lancet 347:188Google Scholar
  111. 111.
    Hemilä H (1986) A re-evaluation of nutritional goals — not just deficiency counts. Med Hypotheses 20:17–27PubMedGoogle Scholar
  112. 112.
    Herbert V (1993) Does mega-C do more good than harm, or more harm than good? Nutr Today 28(1):28–32Google Scholar
  113. 113.
    Newmark HL, Scheiner JM, Marcus M, Prabhudesai M (1979) Ascorbic acid and vitamin B12. JAMA 242:2319–2320PubMedGoogle Scholar
  114. 114.
    Marcus M (1981) Vitamin B12: response to Dr. Herbert. Am J Clin Nutr 34:1622–1624Google Scholar
  115. 115.
    Hemilä H (1994) The good and harm of vitamin C. Nutr Today 29(2):49–50Google Scholar
  116. 116.
    Hanck A (1982) Tolerance and effects of high doses of ascorbic acid. Int J Vitam Nutr Res [Suppl 23]:221–238Google Scholar
  117. 117.
    Bendich A, Langseth L (1995) The health effects of vitamin C supplementation. J Am Coll Nutr 14:124–136 and 398PubMedGoogle Scholar
  118. 118.
    Marinacci B (1995) Linus Pauling in his own words. Simon and Schuster, New York, pp 249–251Google Scholar
  119. 119.
    Knipschild P (1994) Systematic reviews. Some examples. BMJ 309:719–721PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1998

Authors and Affiliations

  • H. Hemilä
    • 1
  1. 1.Department of Public HealthUniversity of HelsinkiFinland

Personalised recommendations